This is a six center, double-blind, placebo-controlled study to determine if the administration of oral doxycycline will decrease the severity or progression of osteoarthritis (OA) in females. This is a 30 month clinical trial. Because the pathologic changes of OA progress slowly, obese women between ages of 45-64 with radiographic evidence of unilateral knee OA will be used as subjects. Our primary outcome measure will be radiographic OA progression in the contralateral knee.
Showing the most recent 10 out of 859 publications